Zobrazeno 1 - 10 of 105 pro vyhledávání: '"Sebastian E, Serfling"'
1
Akademický článek
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL
Autor: Rudolf A. Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Takahiro Higuchi, Philipp Hartrampf, Sebastian E. Serfling, Thorsten Derlin, Constantin Lapa, Andreas K. Buck, Markus Essler, Kenneth J. Pienta, Mario A. Eisenberger, Mark C. Markowski, Laura Shinehouse, Rehab AbdAllah, Ali Salavati, Martin A. Lodge, Martin G. Pomper, Michael A. Gorin, Ralph A. Bundschuh, Steven P. Rowe
Publikováno v: Molecular Imaging, Vol 2022 (2022)
Objectives. In patients with prostate cancer (PC) receiving prostate-specific membrane antigen- (PSMA-) targeted radioligand therapy (RLT), higher baseline standardized uptake values (SUVs) are linked to improved outcome. Thus, readers deciding on RL
Externí odkaz: https://doaj.org/article/5bfc1256bc1347abb2e5c98b1daffdae
Zobrazit plný text záznamu
4
Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors
Autor: Aleksander Kosmala, Sebastian E. Serfling, Wiebke Schlötelburg, Thomas Lindner, Kerstin Michalski, Andreas Schirbel, Takahiro Higuchi, Philipp E. Hartrampf, Andreas K. Buck, Alexander Weich, Rudolf A. Werner
Publikováno v: Clinical Nuclear Medicine. 48:35-42
We aimed to determine the impact of fibroblast activation protein inhibitor (FAPI)-directed molecular imaging on staging and therapeutic management in patients affected with digestive system tumors when compared with guideline-compatible imaging (GCI
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4248238d3362927dc5dc04f4a030a45e
https://doi.org/10.1097/rlu.0000000000004480
Zobrazit plný text záznamu
5
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
Autor: Philipp E. Hartrampf, Ralph A. Bundschuh, Franz-Xaver Weinzierl, Sebastian E. Serfling, Aleksander Kosmala, Anna Katharina Seitz, Hubert Kübler, Andreas K. Buck, Markus Essler, Rudolf A. Werner
Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging. 49:4727-4735
Introduction In men with metastatic castration-resistant prostate cancer (mCRPC) scheduled for prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT), biochemical response is assessed based on repeated measurements of prostate-s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed37abbd8884495fffd2cb9c9206e89f
https://doi.org/10.1007/s00259-022-05910-w
Zobrazit plný text záznamu
7
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors
Autor: Aleksander Kosmala, Sebastian E. Serfling, Kerstin Michalski, Thomas Lindner, Andreas Schirbel, Takahiro Higuchi, Philipp E. Hartrampf, Thorsten Derlin, Andreas K. Buck, Alexander Weich, Rudolf A. Werner
Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging.
Purpose We aimed to assess prevalence, distribution, and intensity of in-vivo arterial wall fibroblast activation protein (FAP) uptake, and its association with calcified plaque burden, cardiovascular risk factors (CVRFs), and FAP-avid tumor burden.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ffbf4512178215f857a77ec89f9af90a
https://doi.org/10.1007/s00259-023-06245-w
Zobrazit plný text záznamu
9
C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
Autor: Andreas K. Buck, Götz Ulrich Grigoleit, Sabrina Kraus, Andreas Schirbel, Michael Heinsch, Niklas Dreher, Takahiro Higuchi, Constantin Lapa, Heribert Hänscheid, Samuel Samnick, Hermann Einsele, Sebastian E. Serfling, Rudolf A. Werner
Publikováno v: J Nucl Med
C-X-C motif chemokine receptor 4 (CXCR4)–targeted radioligand therapy (RLT) has already been applied to advanced blood cancers, such as multiple myeloma or diffuse large B-cell lymphoma. We present a series of patients with advanced T-cell lymphoma
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481dc738a6ebc26ed5c22f13a3691d5e
https://doi.org/10.2967/jnumed.122.264207
Zobrazit plný text záznamu
10
CXCR4-targeted theranostics in oncology
Autor: Andreas K. Buck, Sebastian E. Serfling, Thomas Lindner, Heribert Hänscheid, Andreas Schirbel, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Rudolf A. Werner
Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging. 49:4133-4144
A growing body of literature reports on the upregulation of C-X-C motif chemokine receptor 4 (CXCR4) in a variety of cancer entities, rendering this receptor as suitable target for molecular imaging and endoradiotherapy in a theranostic setting. For
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9985793e43ad015b27f95bc3866bf1d
https://doi.org/10.1007/s00259-022-05849-y
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje